Please note that BARDA has pandemic influenza (PI) and emerging infectious diseases (EID) as part of their mission and that their goal is to get medical countermeasures FDA approved, and manufactured, to be included in our national stockpile. IPIX will not have to pay a penny to advance Brilacidin. Uncle Sam will be the first customer and the biggest.


“Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response, was established to aid in securing our nation from chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI) and emerging infectious diseases (EID). BARDA supports the transition of medical countermeasures such as vaccines, drugs, and diagnostics from research through advanced development towards consideration for approval by the FDA and inclusion into the Strategic National Stockpile. BARDA’s support includes funding, technical assistance and core services, ranging from a clinical research organization network to Centers for Innovation in Advanced Development and Manufacturing, and a fill-finish manufacturing network. To-date, BARDA has supported 42 FDA approvals for products addressing CBRN, PI, and EID threats”


https://www.phe.gov/about/barda/Pages/default.aspx